Publications scientifiques

2602 PUBLICATIONS

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

ANNÉE2021

JOURNALLung cancer (Amsterdam, Netherlands)

PREMIER AUTEURDebieuvre D

TITRETwo-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada.

ANNÉE2021

JOURNALNanomedicine : nanotechnology, biology, and medicine

PREMIER AUTEURRammal H

TITREInvestigation of squalene-doxorubicin distribution and interactions within single cancer cell using Raman microspectroscopy.

ANNÉE2021

JOURNALAmerican journal of hematology

PREMIER AUTEURDuléry R

TITREProlonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy.

ANNÉE2021

JOURNALInternational journal of computer assisted radiology and surgery

PREMIER AUTEURLazo JF

TITREUsing spatial-temporal ensembles of convolutional neural networks for lumen segmentation in ureteroscopy.

ANNÉE2021

JOURNALThe oncologist

PREMIER AUTEURThiery-Vuillemin A

TITREPost hoc health-related quality of life analysis according to response among patients with prostate cancer in the PROSELICA and FIRSTANA studies.

ANNÉE2021

JOURNALDiagnostic and interventional imaging

PREMIER AUTEURDe Marini P

TITRESafety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers.

ANNÉE2021

JOURNALAnnals of surgical oncology

PREMIER AUTEURLecointre L

TITREStatus of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group.

ANNÉE2021

JOURNALOncoimmunology

PREMIER AUTEURAngelova M

TITREEvasion before invasion: Pre-cancer immunosurveillance.

ANNÉE2021

JOURNALPharmaceuticals (Basel, Switzerland)

PREMIER AUTEURDaouk J

TITRETerbium-Based AGuIX-Design Nanoparticle to Mediate X-ray-Induced Photodynamic Therapy.

ANNÉE2021

JOURNALGenes

PREMIER AUTEURAbdullah O

TITREThymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex.

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques